The big picture. Forum for long holder

Patents Assigned to Avita Medical Ltd.

• step 1 - burns (complete with further usage in progress e.g. mobile patients)
  
  Cell suspension preparation technique and device
  Patent number: 10729536

  Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.

  Type: Grant

  Filed: December 12, 2017

  Date of Patent: August 4, 2020

  Assignee: AVITA MEDICAL LTD

  Inventors: Fiona M. Wood, Marie L. Stoner
• Cell suspension preparation technique and device
  Patent number: 10631974

  Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.

  Type: Grant

  Filed: June 10, 2019

  Date of Patent: April 28, 2020

  Assignee: AVITA MEDICAL LTD

  Inventors: Fiona M. Wood, Marie L. Stoner
• Step 2 (or whenever they are ready) a patent ensuring alteration of abnormal cells is on the cards.
  
  
  Systems and methods for tissue processing and preparation of cell suspension therefrom I
  Patent number: 10626358

  Abstract: The present invention provides for methods and at least partially automated devices suitable for producing a transplantable cellular suspension of living tissue suit Oi able for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. Tissue regeneration in humans is extremely limited and constitutes a major challenge to the repair of damaged organ function. Wound treatment is a typical area where tissue regeneration is required. Wounds (lacerations or o I’m penings) in mammalian tissue can result in tissue disruption and coagulation of the microvasculature at the wound face.

  Type: Grant

  Filed: March 14, 2014

  Date of Patent: April 21, 2020

  Assignee: AVITA MEDICAL LTD

  Inventors: Andrew Perry Quick, David Allen Fencil, William Ford Dolphin
• Cell suspension preparation technique and device
  Patent number: 9867692

  Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.

  Type: Grant

  Filed: March 12, 2015

  Date of Patent: January 16, 2018

  Assignee: Avita Medical Ltd.

  Inventors: Fiona M. Wood, Marie L. Stoner
  
  
• Step 3 - wound regeneration using transplantable cellular goodies. Tick.
• 
  Systems and Methods for Tissue Processing and Preparation of Cell Suspension Therefrom
• Publication number: 20160024450

  Abstract: The present invention provides for methods and at least partially automated devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. Tissue regeneration in humans is extremely limited and constitutes a major challenge to the repair of damaged organ function. Wound treatment is a typical area where tissue regeneration is required. Wounds (lacerations or openings) in mammalian tissue can result in tissue disruption and coagulation of the microvasculature at the wound face.

  Type: Application

  Filed: March 14, 2014

  Publication date: January 28, 2016

  Applicant: AVITA MEDICAL LTD.

  Inventors: Andrew Perry Quick, David Allen Fencil, William Ford Dolphin
• Cell Suspension and Use Thereof
  Publication number: 20150079153

  Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. The cellular suspension can include viable and functioning cells at various stages of differentiation, including undifferentiated/progenitor cells and differentiated cells, as well as those in between. In certain embodiments, the cellular suspension can be subjected to a stress to induce a heat shock response therein, or be exposed to an exogenously supplied agent such as heat shock protein or a fragment thereof, hyaluronic acid, platelet-enriched plasma, and/or growth factors. The cellular suspension can be applied directly to a patient's recipient site for in vivo regeneration, or be cultured or seeded to a matrix for in vitro growth/regeneration.

  Type: Application

  Filed: March 14, 2013

  Publication date: March 19, 2015

  Applicant: Avita Medical Ltd.

  Inventors: Andrew Quick, William Dolphin

Mate. That’s some powerful (and patented) IP. This will be very large. Hold tight and trust your instincts. Good things take time. Hold news is stage 1 is well deployed. Next stages will already have a highly trained base to pounce from. Good luck all